BETHLEHEM, Pa., May 13, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), Walgreens (NYSE:WAG), and the Chronic Liver Disease Foundation announced today that they have joined with local health organizations to offer hepatitis C (HCV) testing with the OraQuick® HCV Rapid Test to individuals who may be at risk for HCV infection. The testing will be available in select Walgreens locations across 11 states in observance of National Hepatitis Testing Day, May 19. The on-site testing, patient education and linkage to care will be conducted by local health organizations. National Hepatitis Testing Day was established by the Centers for Disease Control and Prevention (CDC) as an opportunity to remind healthcare providers and those individuals at risk that they should be tested for viral hepatitis.
OraSure Technologies, Walgreens And Chronic Liver Disease Foundation To Launch Rapid Hepatitis C Testing Initiative In Support Of National Hepatitis Testing Day
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.